JD Supra20h
The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know
This past July, we reported on the Centers for Medicare & Medicaid Services (CMS) release of the 2025 proposed Hospital Outpatient Prospective ...
Reuters1d
Sanofi plans to change hospital drug-discount program
Sanofi's new plan will require institutions to provide pharmacy and medical claims information, such as the drug's order or a ...
Clonazepam recall expanded after misprinting on packaging
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Nationwide Recall of Anxiety Drug Over Life-Threatening Packaging Error
Endo Inc., based in Pennsylvania, has announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets ...
Holiday Shoppers Beware: 3 Traps to Avoid as Scammers Prepare
Black Friday is fast approaching, and shoppers are gearing up. The National Retail Federation expects more than 183 million ...
What’s Behind the Remarkable Drop in U.S. Overdose Deaths
Experts are puzzling over which interventions are saving lives. The evolving illicit supply itself may hold important clues.
Urine sample match triggers trots drug testing scandal
Two up-and-coming Sydney drivers provided samples to stewards at a race meeting in Goulburn. DNA analysis showed the urine in both was from the same person.
Nationwide Recall of Supplement Due to Life-Threatening Drug Contamination
Supplements labeled as hyaluronic acid are being recalled because they contain undeclared drugs, which could be dangerous.
What’s the Difference Between the FDA and the USDA?
The FDA regulates packaged milk and dairy in the U.S., including yogurt, sour cream, cheese, and ice cream that does not ...
FiercePharma3d
Roche files patent suit to fend off potential Evrysdi generics from Zydus, Natco
Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are ...
FiercePharma3d
Endo expands clonazepam recall to cover more than a dozen additional batches
After a labeling mix-up prompted a recall of a popular panic disorder drug this summer, Endo’s U.S. subsidiary is widening the scope of its product pull. | Endo USA is expanding its previous recall of ...